PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
54.58
ESG score 80-90% of BTAI's 61.02. Walter Schloss would scrutinize governance quality and regulatory exposure.
49.62
Environmental score 80-90% of BTAI's 56.46. Walter Schloss would scrutinize carbon exposure and transition planning.
57.51
Social score 90-95% of BTAI's 63.52. Bill Ackman would demand clear social improvement catalysts.
56.60
Governance score 80-90% of BTAI's 63.09. Walter Schloss would scrutinize management accountability and board independence.